EverQuote, Inc. (NASDAQ:EVER – Get Free Report) Director John Shields sold 3,126 shares of the firm’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $26.39, for a total value of $82,495.14. Following the sale, the director directly owned 31,198 shares of the company’s stock, valued at $823,315.22. This represents a 9.11% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
EverQuote Price Performance
NASDAQ:EVER opened at $24.82 on Friday. EverQuote, Inc. has a one year low of $13.88 and a one year high of $28.73. The company has a market cap of $894.26 million, a P/E ratio of 8.06 and a beta of 0.62. The firm’s fifty day moving average price is $24.74 and its two-hundred day moving average price is $19.76.
EverQuote (NASDAQ:EVER – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.52 by $0.01. EverQuote had a net margin of 15.16% and a return on equity of 50.29%. The business had revenue of $195.09 million during the quarter, compared to the consensus estimate of $191.06 million. During the same quarter in the previous year, the firm posted $0.39 EPS. EverQuote’s revenue was up 24.6% compared to the same quarter last year. As a group, equities research analysts expect that EverQuote, Inc. will post 1.72 earnings per share for the current year.
Hedge Funds Weigh In On EverQuote
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on EVER shares. B. Riley Financial reissued a “buy” rating and set a $34.00 target price (up from $30.00) on shares of EverQuote in a report on Tuesday, August 4th. Raymond James Financial reissued an “outperform” rating and issued a $28.00 price target on shares of EverQuote in a report on Thursday, August 13th. JPMorgan Chase & Co. began coverage on shares of EverQuote in a research note on Monday. They issued an “overweight” rating and a $29.00 target price on the stock. Wall Street Zen lowered EverQuote from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings raised shares of EverQuote from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $28.17.
Check Out Our Latest Stock Analysis on EverQuote
About EverQuote
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
Read More
- Five stocks we like better than EverQuote
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
